These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12451243)

  • 1. Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy.
    Shimada T; Terada A; Yokogawa K; Kaneko H; Nomura M; Kaji K; Kaneko S; Kobayashi K; Miyamoto K
    Transplantation; 2002 Nov; 74(10):1419-24. PubMed ID: 12451243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone.
    Yokogawa K; Shimada T; Higashi Y; Itoh Y; Masue T; Ishizaki J; Asahi M; Miyamoto K
    Biochem Pharmacol; 2002 Feb; 63(4):777-83. PubMed ID: 11992648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats.
    Perloff MD; von Moltke LL; Greenblatt DJ
    Xenobiotica; 2004 Feb; 34(2):133-50. PubMed ID: 14985144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2.
    Mei Q; Richards K; Strong-Basalyga K; Fauty SE; Taylor A; Yamazaki M; Prueksaritanont T; Lin JH; Hochman J
    J Pharm Sci; 2004 Oct; 93(10):2488-96. PubMed ID: 15349958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.
    Shimada T; Aoki Y; Yokogawa K; Nomura M; Ishizaki J; Nishigami J; Miyamoto K
    Transpl Int; 2003 Nov; 16(11):788-93. PubMed ID: 12844214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
    Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK
    Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
    Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
    Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
    Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers.
    Salphati L; Benet LZ
    Biochem Pharmacol; 1998 Feb; 55(4):387-95. PubMed ID: 9514072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats.
    Hashimoto Y; Sasa H; Shimomura M; Inui K
    Pharm Res; 1998 Oct; 15(10):1609-13. PubMed ID: 9794505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .
    Lin JH; Chiba M; Chen IW; Nishime JA; deLuna FA; Yamazaki M; Lin YJ
    Drug Metab Dispos; 1999 Oct; 27(10):1187-93. PubMed ID: 10497146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients.
    Masuda S; Goto M; Okuda M; Ogura Y; Oike F; Kiuchi T; Tanaka K; Inui K
    Transplant Proc; 2005 May; 37(4):1728-9. PubMed ID: 15919446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands.
    Marsaud V; Mercier-Bodard C; Fortin D; Le Bihan S; Renoir JM
    J Steroid Biochem Mol Biol; 1998 Jul; 66(1-2):11-25. PubMed ID: 9712407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of lower maintenance dose of tacrolimus in obese patients.
    Sawamoto K; Huong TT; Sugimoto N; Mizutani Y; Sai Y; Miyamoto K
    Drug Metab Pharmacokinet; 2014; 29(4):341-7. PubMed ID: 24670405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient.
    Masuda S; Uemoto S; Hashida T; Inomata Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2000 Jul; 68(1):98-103. PubMed ID: 10945321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice.
    Yokogawa K; Takahashi M; Tamai I; Konishi H; Nomura M; Moritani S; Miyamoto K; Tsuji A
    Pharm Res; 1999 Aug; 16(8):1213-8. PubMed ID: 10468022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients.
    Masuda S; Uemoto S; Goto M; Fujimoto Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2004 Apr; 75(4):352-61. PubMed ID: 15060513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation by dexamethasone of fluvastatin-inducible CYP2B expression in primary cultures of rat hepatocytes: role of CYP3A.
    Kocarek TA; Reddy AB
    Biochem Pharmacol; 1998 May; 55(9):1435-43. PubMed ID: 10076536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic determinant of the drug interaction between tacrolimus and omeprazole.
    Zhao W; Fakhoury M; Maisin A; Baudouin V; Storme T; Deschênes G; Jacqz-Aigrain E
    Ther Drug Monit; 2012 Dec; 34(6):739-41. PubMed ID: 23042259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation.
    Masuda S; Goto M; Kiuchi T; Uemoto S; Kodawara T; Saito H; Tanaka K; Inui K
    Liver Transpl; 2003 Oct; 9(10):1108-13. PubMed ID: 14526408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.